Blood pressure control during breast cancer chemo
Part of Cancer, Heart & circulation, Injuries & trauma, Skin clinical trials.
This study tests whether careful blood pressure management can help protect the heart during certain types of chemotherapy (anthracyclines) for breast cancer. Participants will use a smart blood pressure device and may also do an exercise test.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You were assigned female at birth
- You have breast cancer (any stage I through IV)
- You are getting at least 2 cycles of anthracycline-based chemotherapy (a type of chemo that can stress the heart)
- Your systolic blood pressure (top number) is 130 or higher
- You don't have a serious heart condition like heart failure, recent heart attack, or history of stroke
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how breast cancer medicines affect the heart. It may help doctors better prevent, spot early, and manage heart side effects from trastuzumab and/or anthracycline chemotherapy.
This study tests a supervised exercise program for people with breast cancer who are about to start or are already in chemotherapy. The goal is to see if this type of rehabilitation helps keep your heart strong and improves your overall well-being during treatment.
This study watches how chemotherapy and HER2-targeted drugs affect your heart during early-stage breast cancer treatment. Researchers use heart scans to catch any changes early and understand how to protect heart health.
This study tests whether supervised exercise during chemotherapy is safe and helpful for people with early-stage breast cancer. It may support physical function and well-being while you are receiving cancer treatment.
This trial checks how well the heart handles anthracycline chemotherapy in breast cancer patients. It helps doctors find early signs of heart side effects so they can keep you safe during treatment.
This study tests a method to predict and warn about heart damage from a common type of breast cancer chemotherapy. If you have HER2-positive breast cancer and will receive anthracycline drugs, this trial may help monitor your heart health.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.